Jens R. Fogh
Lynge, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Analysis of cathepsin B and cathepsin L treatment to clear toxic lysosomal protein aggregates in neuronal ceroid lipofuscinosis.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 24, 2021
Investigating surrogate cerebrospinal fluid matrix compositions for use in quantitative LC-MS analysis of therapeutic antibodies in the cerebrospinal fluid.
Journal: Analytical and bioanalytical chemistry
Published: August 16, 2019
Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis.
Journal: Autophagy
Published: July 09, 2019
Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial.
Journal: Journal of inherited metabolic disease
Published: June 16, 2017
Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis.
Journal: Journal of inherited metabolic disease
Published: June 16, 2017
Long-term enzyme replacement therapy improves neurocognitive functioning and hippocampal synaptic plasticity in immune-tolerant alpha-mannosidosis mice.
Journal: Neurobiology of disease
Published: May 02, 2017
Chronic enzyme replacement therapy ameliorates neuropathology in alpha-mannosidosis mice.
Journal: Annals of clinical and translational neurology
Published: July 06, 2015
Cognitive profile and activities of daily living: 35 patients with alpha-mannosidosis.
Journal: Journal of inherited metabolic disease
Published: February 22, 2015
Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Journal: Experimental neurology
Published: February 12, 2015
Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation.
Journal: Orphanet journal of rare diseases
Published: February 09, 2015
Last Updated: 09/26/2026